128 related articles for article (PubMed ID: 9804398)
1. Immunoradiometric assay of thyroglobulin in patients with differentiated thyroid carcinomas: need for thyroglobulin recovery tests.
Bourrel F; Hoff M; Regis H; Courrière P; Caron P
Clin Chem Lab Med; 1998 Sep; 36(9):725-30. PubMed ID: 9804398
[TBL] [Abstract][Full Text] [Related]
2. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?
Mariotti S; Barbesino G; Caturegli P; Marinó M; Manetti L; Pacini F; Centoni R; Pinchera A
J Clin Endocrinol Metab; 1995 Feb; 80(2):468-72. PubMed ID: 7852506
[TBL] [Abstract][Full Text] [Related]
3. High-sensitive 2nd generation thyroglobulin immunoradiometric assay. Clinical application in differentiated thyroid cancer management.
Giovanella L; Ceriani L; Garancini S
Q J Nucl Med; 2002 Dec; 46(4):319-22. PubMed ID: 12411872
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of two methods to assay thyroglobulin serum concentrations in patients with differentiated thyroid carcinomas.
Ferrari L; Seregni E; Aliberti G; Martinetti A; Pallotti F; Villano C; Lucignani G; Bombardieri E
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):237-42. PubMed ID: 15499298
[TBL] [Abstract][Full Text] [Related]
5. High-sensitivity human thyroglobulin (hTG) immunoradiometric assay in the follow-up of patients with differentiated thyroid cancer.
Giovanella L; Ceriani L
Clin Chem Lab Med; 2002 May; 40(5):480-4. PubMed ID: 12113292
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of efficacy of various methods of thyroglobulin measurements in differentiated thyroid cancer].
Czernik E; Deja R; Gubała E; Kukulska A; Turska M; Dabrowska-Czuba E; Bartnikowa W; Jarzab B
Wiad Lek; 2001; 54 Suppl 1():339-48. PubMed ID: 12182046
[TBL] [Abstract][Full Text] [Related]
7. [Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of different thyroid carcinoma].
Zöphel K; Wunderlich G; Liepach U; Koch R; Bredow J; Franke WG
Nuklearmedizin; 2001 Oct; 40(5):155-63. PubMed ID: 11727628
[TBL] [Abstract][Full Text] [Related]
8. Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up.
Weightman DR; Mallick UK; Fenwick JD; Perros P
Cancer; 2003 Jul; 98(1):41-7. PubMed ID: 12833453
[TBL] [Abstract][Full Text] [Related]
9. Critical aspects of immunoradiometric thyroglobulin assays.
Ferrari L; Biancolini D; Seregni E; Aliberti G; Martinetti A; Villano C; Pallotti F; Chiesa C; Bombardieri E
Tumori; 2003; 89(5):537-9. PubMed ID: 14870780
[TBL] [Abstract][Full Text] [Related]
10. Differences in serum thyroglobulin measurements by 3 commercial immunoradiometric assay kits and laboratory standardization using Certified Reference Material 457 (CRM-457).
Lee JI; Kim JY; Choi JY; Kim HK; Jang HW; Hur KY; Kim JH; Kim KW; Chung JH; Kim SW
Head Neck; 2010 Sep; 32(9):1161-6. PubMed ID: 20029980
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two thyroglobulin immunoradiometric assays on the basis of comprehensive imaging in differentiated thyroid carcinoma.
Mikosch P; Gallowitsch HJ; Kresnik E; Unterweger O; Gomez I; Lind P
Thyroid; 1999 Sep; 9(9):933-41. PubMed ID: 10524573
[TBL] [Abstract][Full Text] [Related]
12. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.
Spencer CA; Takeuchi M; Kazarosyan M; Wang CC; Guttler RB; Singer PA; Fatemi S; LoPresti JS; Nicoloff JT
J Clin Endocrinol Metab; 1998 Apr; 83(4):1121-7. PubMed ID: 9543128
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the BRAHMS Kryptor(®) thyroglobulin minirecovery test in patients with differentiated thyroid carcinoma.
Giovanella L; Imperiali M; Verburg FA; Ceriani L
Clin Chem Lab Med; 2013 Feb; 51(2):449-53. PubMed ID: 23095203
[TBL] [Abstract][Full Text] [Related]
14. [Inappropriately undetectable thyroglobulin after exclusion of interference from thyroglobulin antibodies].
Munier P; Courtier F; Barrial K; Chikh K; Claustrat F; Le Bricon T; Bronner J; Sanabria E
Ann Biol Clin (Paris); 2011; 69(6):721-5. PubMed ID: 22123574
[TBL] [Abstract][Full Text] [Related]
15. Anti-thyroglobulin antibodies in differentiated thyroid carcinoma patients: Study of the clinical and biological parameters.
Rahmoun MN; Bendahmane I
Ann Endocrinol (Paris); 2014 Feb; 75(1):15-8. PubMed ID: 24560398
[TBL] [Abstract][Full Text] [Related]
16. Importance of the detection method for thyroglobulin antibodies for the validity of thyroglobulin measurements in sera from patients with Graves disease.
Massart C; Maugendre D
Clin Chem; 2002 Jan; 48(1):102-7. PubMed ID: 11751544
[TBL] [Abstract][Full Text] [Related]
17. Multiplexed immunoassay of thyroglobulin autoantibodies in patients with differentiated thyroid carcinoma.
Giovanella L; Toffalori E; Tozzoli R; Caputo M; Ceriani L; Verburg FA
Head Neck; 2012 Oct; 34(10):1369-71. PubMed ID: 22083639
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M
Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893
[TBL] [Abstract][Full Text] [Related]
19. Concordance between thyroglobulin antibody assays.
Taylor KP; Parkington D; Bradbury S; Simpson HL; Jefferies SJ; Halsall DJ
Ann Clin Biochem; 2011 Jul; 48(Pt 4):367-9. PubMed ID: 21502198
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of a new thyroglobulin immunoradiometric assay in the follow-up of differentiated thyroid carcinoma].
Sahlmann CO; Schreivogel I; Angerstein C; Siefker U; Lehmann K; Altenvoerde G; Hüfner M; Meller J
Nuklearmedizin; 2003; 42(2):71-7. PubMed ID: 12695789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
